ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Mechanisms might be attributed to the characteristic of ASXL1 being latent, initiating mutations that accumulate during the progression of CML, and the protein encoded by ASXL1 has a mutual effect with BCR∷ABL1 [17,18].